The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Corcept Therapeutics Inc shares valued at $1,409,848 were sold by Guyer William on Sep 02 ’25. At $70.49 per share, Guyer William sold 20,000 shares. The insider’s holdings dropped to 5,487 shares worth approximately $0.38 million following the completion of this transaction.
Also, Lyon Joseph Douglas sold 5,000 shares, netting a total of over 351,247 in proceeds. Following the sale of shares at $70.25 each, the insider now holds 10,066 shares.
Before that, Maduck Sean had sold 20,000 shares from its account. In a trade valued at $1,409,828, the insider traded Corcept Therapeutics Inc shares for $70.49 each. Upon closing the transaction, the insider’s holdings decreased to 20,000 shares, worth approximately $0.53 million.
As published in a research note from Truist on November 06, 2023, Corcept Therapeutics Inc [CORT] has been rated up from a Hold to a Buy and the price target has been revised to $38 from $29. Analysts at SVB Securities started covering the stock with ‘”a Market perform”‘ outlook in a report released in mid April. As of April 04, 2023, Piper Sandler has initiated its “an Overweight” rating for CORT. Earlier on February 15, 2023, Jefferies downgraded its rating. Their new recommendation was “a Hold” for CORT stock which previously was a “a Buy”.
Analyzing CORT Stock Performance
On last trading session, Corcept Therapeutics Inc [NASDAQ: CORT] plunged -2.76% to $69.37. The stock’s lowest price that day was $69.07, but it reached a high of $71.955 in the same session. During the last five days, there has been a drop of approximately -0.52%. Over the course of the year, Corcept Therapeutics Inc shares have jumped approximately 96.52%. Shares of the company reached a 52-week high of $117.33 on 03/31/25 and a 52-week low of $49.00 on 01/13/25.
Support And Resistance Levels for Corcept Therapeutics Inc (CORT)
According to the 24-hour chart, there is a support level at 68.29, which, if violated, would cause prices to drop to 67.21. In the upper region, resistance lies at 71.20. The next price resistance is at 73.04. RSI (Relative Strength Index) is 44.97 on the 14-day chart, showing neutral technical sentiment.
Is Corcept Therapeutics Inc subject to short interest?
Stocks of Corcept Therapeutics Inc saw a sharp steep in short interest on 2025-08-15 dropping by -0.63 million shares to 10.59 million. Data from Yahoo Finance shows that the short interest on 2025-07-15 was 11.22 million shares. A decline of -5.97% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 12.5 of the overall float, the days-to-cover ratio (short ratio) decline to 12.5.
Which companies own the most shares of Corcept Therapeutics Inc (CORT)?
In terms of Corcept Therapeutics Inc share price expectations, FactSet research, analysts set an average price target of 140 in the next 12 months, up nearly 96.24% from the previous closing price of $71.34. Analysts anticipate Corcept Therapeutics Inc stock to reach 145 by 2025, with the lowest price target being 135. In spite of this, 4 analysts ranked Corcept Therapeutics Inc stock as Buy at the end of 2025. On August 01, 2022, Truist assigned a price target of “a Hold” to the stock and downgraded coverage with a $30.
